Tilray Brands, Inc. - Common Stock (TLRY)
0.9505
+0.00 (0.00%)
NASDAQ · Last Trade: Aug 13th, 7:13 AM EDT
Detailed Quote
Previous Close | 0.9505 |
---|---|
Open | - |
Bid | 0.9900 |
Ask | 0.9986 |
Day's Range | N/A - N/A |
52 Week Range | 0.3507 - 1.980 |
Volume | 874,301 |
Market Cap | 694.14M |
PE Ratio (TTM) | -0.3944 |
EPS (TTM) | -2.4 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 58,086,711 |
Chart
About Tilray Brands, Inc. - Common Stock (TLRY)
Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products. The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide. Read More
News & Press Releases
Tilray’s FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies
By Tilray Brands, Inc. · Via GlobeNewswire · August 13, 2025
Cannabis company Tilray Brands (NASDAQ:TLRY) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 2.3% year on year to $224.5 million. Its GAAP loss of $1.30 per share was significantly below analysts’ consensus estimates.
Via StockStory · August 12, 2025
Tilray’s second quarter was met with a significant negative market reaction, as the company missed Wall Street’s revenue and earnings expectations. Management attributed the underperformance primarily to delayed export permits in Europe, ongoing consumer softness in its beverage division, and strategic SKU rationalization efforts across its portfolio. CEO Irwin Simon noted that “approximately $8 million” in international cannabis sales were delayed due to regulatory challenges in Portugal and Spain, and the beverage segment saw lower volumes as it completed integration of recent acquisitions. Strategic choices to prioritize higher-margin products and cost efficiencies also led to lower near-term sales, reflecting a cautious tone from leadership regarding current market conditions.
Via StockStory · August 12, 2025
Microcap Cannabis Stock VFF Is Having A ‘Trump Pump’ Moment — And Retail Traders Feel Bullish Ahead Of Q2 Earningsstocktwits.com
Via Stocktwits · August 10, 2025
Cannabis stocks and ETFs skyrocketed after Trump hinted at reclassifying marijuana. Tilray surged 35% in 2 days. Other top performers included Trulieve, Tilray, Curaleaf, and Canopy Growth. This shift could ease federal regulations and improve the industry's growth potential.
Via Benzinga · August 12, 2025
Tuesday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!
Via Chartmill · August 12, 2025
A number of stocks jumped in the morning session after the release of a favorable Consumer Price Index (CPI) report, which showed inflation cooling more than anticipated. The July report from the Bureau of Labor Statistics indicated a year-over-year inflation rate of 2.7%, just below the 2.8% economists had forecast. This suggests that price pressures on consumers may be easing. Particularly beneficial for the sector was the news that the food index remained flat, with grocery prices even declining by 0.1% month-over-month. This development is seen as a positive for the profitability of food, beverage, and personal care companies, as lower input costs and increased consumer purchasing power could boost sales.
Via StockStory · August 12, 2025
Tilray rolls out 10mg hemp-derived THC drinks as Trump weighs cannabis reclassification, potentially easing federal barriers and widening U.S. access.
Via Benzinga · August 12, 2025
Via Benzinga · August 12, 2025
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (NASDAQ: TLRY and TSX: TLRY) is building on the momentum of its hemp-derived Delta-9 THC (HDD9) beverage portfolio with new 10mg format extensions from its brands: Fizzy Jane’s and Happy Flower.
By Tilray Brands, Inc. · Via GlobeNewswire · August 12, 2025
U.S. stock futures were swinging between gains and losses on Tuesday following Monday's decline. Futures of benchmark indices were mixed.
Via Benzinga · August 12, 2025
Tilray stock surged 14.13% after hours as reports of a possible marijuana reclassification by Trump fueled investor optimism.
Via Benzinga · August 12, 2025
U.S. stocks closed lower on Monday, with the Dow Jones Industrial Average slipping 0.45% to 43,975.09
Via Benzinga · August 11, 2025
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
jumped 38.5% in the afternoon session after reports that President Donald Trump is considering reclassifying marijuana as a less dangerous drug, a move that could transform the cannabis industry's regulatory landscape.
Via StockStory · August 11, 2025
Via Benzinga · August 11, 2025
Get a pulse on the US markets on Monday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
Via Chartmill · August 11, 2025
Trump Confirms Marijuana Reclassification Decision To Be Made In ‘Next Few Weeks’stocktwits.com
Via Stocktwits · August 11, 2025
Shares of major cannabis companies are trading higher Monday morning. The stocks are soaring following a WSJ report that President Trump is considering reclassifying marijuana as a less dangerous drug.
Via Benzinga · August 11, 2025
Via Benzinga · August 11, 2025
Via Benzinga · August 11, 2025
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
jumped 4.9% in the afternoon session after the company announced the launch of its new Humble Seed Whole Wheat Protein Crackers, now available at Whole Foods Market. This move marked a notable expansion of the company's wellness product offerings into a major retail chain. The positive sentiment also followed other recent events. Earlier in the week, an analyst upgraded the stock to a "Buy" rating, and at the end of July, CEO Irwin D. Simon purchased 165,000 shares. This insider purchase signaled strong confidence in the company's direction.
Via StockStory · August 7, 2025
The Humble Seed Introduces the Ultimate Protein Snack and Better-for-You Crackers with 5g of Superseed Protein
By Tilray Brands, Inc. · Via GlobeNewswire · August 7, 2025
Spoiler: The answer isn't pretty. In fact, it's worse than ugly.
Via The Motley Fool · August 5, 2025
The company posted an adjusted net profit in its latest reported quarter, but there wasn't much else producing a high for investors.
Via The Motley Fool · August 1, 2025